S6K1 amplification confers innate resistance to CDK4/6 inhibitors through activating c-Myc pathway in patients with estrogen receptor-positive breast cancer

Hongnan Mo(Chinese Academy of Medical Sciences & Peking Union Medical College), Fei Ma(XinHua Hospital), Yu Xue(Dalian Medical University), Jiashu Han(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhangfu Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Caiming Li(Jiangnan University), Yongmei Song(Chinese Academy of Medical Sciences & Peking Union Medical College), Shuang Wang(Dalian Medical University), Hongyan Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Dan Li(Northeast Agricultural University), Xuefeng Liu(Peking University Shenzhen Hospital), Ming Fu(Chinese Academy of Medical Sciences & Peking Union Medical College), Shichao Guo(Chinese Academy of Medical Sciences & Peking Union Medical College)
Molecular Cancer
August 30, 2022
Cited by 57


Related Papers